We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Riled By Schering-Plough Case, Senators Introduce Bill

Law360 (June 28, 2006, 12:00 AM EDT) -- Four top Senate judiciary committee members are taking matters into their own hands and introducing legislation to prohibit brand-name drug makers from paying rivals to keep generic drugs off the market.

The move comes in reaction to the U.S. Supreme Court’s refusal to hear the U.S. Federal Trade Commission’s appeal in the closely watched Schering-Plough case.

“When big brand-name drug companies pay generic manufacturers to stop generic drugs from reaching pharmacy shelves, consumers lose big-time,” said Sen. Herb Kohl (D-Wis.). “These companies are playing it fast-and-loose...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.